Edge Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$301K Hold
5,447
0.03% 266
2018
Q1
$344K Sell
5,447
-960
-15% -$61.8K 0.03% 254
2017
Q4
$392K Hold
6,407
0.04% 238
2017
Q3
$408K Sell
6,407
-333
-5% -$19.4K 0.04% 233
2017
Q2
$375K Sell
6,740
-207
-3% -$11.3K 0.04% 244
2017
Q1
$377K Sell
6,947
-550
-7% -$30.2K 0.05% 251
2016
Q4
$438K Buy
+7,497
New +$410K 0.06% 230

Other funds holding BMY

Edge Advisors's BMY Position: Q2 2018 in Review

Edge Advisors held its Bristol-Myers Squibb (BMY) position steady in Q2 2018 at 5,447 shares worth $301K. The position accounts for 0.03% of the portfolio, ranked #266.

Edge Advisors first reported a position in BMY in Q4 2016 and has held it in 7 quarters since. The position peaked at $438K in Q4 2016. 1,691 funds tracked by Wall St. Rank hold BMY as of Q2 2018.

  • Edge Advisors held 5,447 shares of Bristol-Myers Squibb worth $301K as of Q2 2018.
  • Edge Advisors left its Bristol-Myers Squibb share count unchanged in Q2 2018.
  • Bristol-Myers Squibb made up 0.03% of Edge Advisors's portfolio in Q2 2018, its #266 holding.
  • Edge Advisors first reported a position in Bristol-Myers Squibb in Q4 2016 and has held it in 7 quarters since.
  • Edge Advisors's Bristol-Myers Squibb position peaked at $438K in Q4 2016.
  • 1,691 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2018.

Based on Edge Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.